About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials | 951 Studies Recruiting

Clinical TrialsBrain Cancer

Brain Cancer Clinical Trials

Browse 951 clinical trials for brain cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 951 trials

RecruitingThe SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.The trial is designed as a multicenter randomized controlled study.NCT03861299·Ghent and 4 others CompletedBevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade GliomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00795665·Sacramento, California

Related Searches

glioblastomatrials gliomatrials brain tumortrials

Data from ClinicalTrials.govTerms

TerminatedMicrotubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaThis Phase I study investigated the side-effects and best dose of microtubule-targeted agent BAL101553 when given together with radiation therapy in treating patients with…NCT03250299·Birmingham, Alabama and 7 others

TerminatedStudy Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent GliomasThis is an open-label, multicenter, Phase 2 study to evaluate the efficacy and safety of oral selinexor in participants with recurrent gliomas.NCT01986348·Boston, Massachusetts and 5 others

CompletedCytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent MedulloblastomaThe purpose of this study is to determine the feasibility and safety of administering CMV RNA-pulsed dendritic cells (DCs), also known as CMV-DCs, to children and young adults up…NCT03615404·Durham, North Carolina

CompletedDendritic Cell Vaccine for Patients With Brain TumorsThe main purpose of this study is to evaluate the most effective immunotherapy vaccine components in patients with malignant glioma.NCT01204684·Los Angeles, California

CompletedCapecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade GliomaRATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00357253·San Francisco, California and 11 others

CompletedCombination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005637·New York, New York

RecruitingStudy of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIThe purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using…NCT07326566·Birmingham, Alabama and 34 others

CompletedVaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Vaccines may help the body build an effective immune response to kill cancer cells. Radiation therapy uses high-energy x-rays to kill cancer cells.NCT00639639·Durham, North Carolina

CompletedPhase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformThe purpose of this study is to investigate the safety and effectiveness of a combination treatment for glioblastoma multiforme utilizing radiotherapy plus the FDA-approved…NCT01120639·Stanford, California

CompletedFluoroethyltyrosine for Evaluation of Intracranial NeoplasmsThis phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have come back.NCT04044937·San Francisco, California

CompletedEffect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)The study is a randomized, controlled trial, designed to test the efficacy and safety of a new medical device, the NovoTTF-100A.NCT00379470·Chicago, Illinois and 24 others

TerminatedRitonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaRATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT01095094·Cleveland, Ohio

CompletedMonoclonal Antibody Therapy in Treating Patients With Recurrent GliomasRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00002753·Durham, North Carolina

CompletedPhase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma MultiformeThe goal of this clinical research study is to find the highest safe dose of the new drug ZARNESTRA (R115777) and temozolomide that can be given to patients with brain tumors…NCT00050986·Houston, Texas

RecruitingA Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasThe purpose of this study is to evaluate whether treating glioblastoma patients with sitagliptin can improve immune response against the tumor by targeting specific immune cells…NCT07003542·Cleveland, Ohio

CompletedPh I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasPrimary Objective: To determine maximum tolerated dose \& dose limiting toxicity of vandetanib when combined with standard dosing of etoposide among patients with recurrent…NCT00613223·Durham, North Carolina

WithdrawnPhase I/II Cabazitaxel for Recurrent Malignant GliomaThe goal of Part 1 of this clinical research study is to find the highest tolerable dose of cabazitaxel that can be given to patients with glioblastoma.NCT01740570

CompletedBevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00720356·Los Angeles, California and 8 others

PreviousPage 10 of 48Next